Concentra Group Holdings Parent
CON
Positions held
Your positionsCON isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Concentra Group Holdings operates in the growing healthcare sector, particularly in medical care facilities, which is expected to expand due to increasing demand for healthcare services.
- Revenue increased by 6% compared to the prior quarter, reaching $606 million.
- Gross margin improved to 31.7%, up from 29.9% in the previous quarter.
- The company's high debt-to-equity ratio of 423.325 may pose financial risks, especially in a rising interest rate environment.
- Trailing P/E ratio stands at 23.48, indicating that the stock may be overvalued relative to its earnings.
- Operating margin has shown fluctuations, with a recent expansion to 19%, but it was only 12.9% in the previous quarter.
Fundamentals
| Market cap | $4.67B | Enterprise value | $6.68B | Trailing P/E | 23.62 | Forward P/E | 19.88 |
| PEG | — | Price / book | 9.79 | Beta | 0.63 | Dividend yield | 0.68% |
| Revenue growth | 10.0% | Earnings growth | 47.0% | Gross margin | 29.3% | Operating margin | 19.3% |
| Profit margin | 8.7% | ROE | 47.1% | ROA | 8.2% | Debt / equity | 4.23 |
| Current ratio | 1.38 | Free cash flow | $204.79M | Analyst recommendation | strong_buy | Mean target | $41.00 |
| 52w high | $36.95 | 52w low | $18.55 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $606M | $570M | $539M | $573M | $551M | — |
| Op margin | 19.0% | 16.8% | 12.9% | 16.5% | 16.3% | — |
| Net income | $65.3M | $50.5M | $34.7M | $48.3M | $44.6M | — |
| Gross margin | 31.7% | 29.9% | 26.1% | 29.2% | 29.3% | — |
| Gross profit | $192M | $170M | $141M | $167M | $161M | — |
| Operating income | $115M | $95.6M | $69.7M | $94.5M | $89.5M | — |
- Revenue +6% vs prior quarter ($606M vs $570M).
- Gross margin 31.7% (was 29.9% prior quarter).
- Operating margin expanded to 19%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.2B | $1.9B | $1.8B | $1.7B | — |
| Op margin | 15.4% | 16.0% | 15.6% | 15.0% | — |
| Net income | $166M | $167M | $180M | $167M | — |
| Gross margin | 28.3% | 27.8% | 27.9% | 27.9% | — |
| Gross profit | $613M | $528M | $512M | $482M | — |
| Operating income | $334M | $305M | $288M | $259M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026
2026-10-08 · Teladoc Strengthens Solo Platform With New AI-Powered Care Tools
2026-10-07 · Encompass Health Expands Rehab Footprint With New Maine Hospital
2026-10-07 · Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?
2026-10-02 · Why Concentra’s Quiet Healthcare Business Keeps Winning
2026-09-28 · CON or MEDP: Which Is the Better Value Stock Right Now?
2026-09-25 · Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?
2026-09-17 · Concentra Group Holdings Parent (CON) Beats Again And Expands In Florida, Is The Stock Still Undervalued?
2026-09-15 · EQ's Concentra awards $150,000 to credit unions strengthening Canadian communities
2026-09-15 · Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
2026-09-14 · Concentra Expands Florida Footprint with New Daytona Beach Medical Center
2026-09-11 · CON vs. MEDP: Which Stock Is the Better Value Option?
Price (daily)
Full chart · RSI · MACD · patterns